We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment for Bowel Cleansing Prior to Colonoscopy
A Randomized, Blinded Trial Comparing Miralax With Amitiza Pretreatment Versus Miralax With Dulcolax Pretreatment Versus Miralax Alone Without Pretreatment for Bowel Cleansing Prior to Colonoscopy
Status: Archived
A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment for Bowel Cleansing Prior to Colonoscopy
Updated: 1/1/1970
A Randomized, Blinded Trial Comparing Miralax With Amitiza Pretreatment Versus Miralax With Dulcolax Pretreatment Versus Miralax Alone Without Pretreatment for Bowel Cleansing Prior to Colonoscopy
Status: Archived
Updated: 1/1/1970
Different Vitamin D Preparations & FGF23 in Humans
Effect of Different Vitamin D Preparations on Circulating FGF23 Levels in Vitamin D Deficient Caucasian and African-American Men and Women
Status: Archived
Different Vitamin D Preparations & FGF23 in Humans
Updated: 1/1/1970
Effect of Different Vitamin D Preparations on Circulating FGF23 Levels in Vitamin D Deficient Caucasian and African-American Men and Women
Status: Archived
Updated: 1/1/1970
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Status: Archived
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Updated: 1/1/1970
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Status: Archived
Updated: 1/1/1970
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Status: Archived
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Updated: 1/1/1970
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Status: Archived
Updated: 1/1/1970
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Status: Archived
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Updated: 1/1/1970
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Status: Archived
Updated: 1/1/1970
Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)
Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE): Esophageal Medication Distribution, Treatment Response, and Effect on the Adrenal Axis.
Status: Archived
Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)
Updated: 1/1/1970
Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE): Esophageal Medication Distribution, Treatment Response, and Effect on the Adrenal Axis.
Status: Archived
Updated: 1/1/1970
Intensive Exercise to Improve Mitochondrial Dysfunction in Pediatric Obesity
Intensive Exercise to Improve Mitochondrial Dysfunction in Pediatric Obesity
Status: Archived
Intensive Exercise to Improve Mitochondrial Dysfunction in Pediatric Obesity
Updated: 1/1/1970
Intensive Exercise to Improve Mitochondrial Dysfunction in Pediatric Obesity
Status: Archived
Updated: 1/1/1970
Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma
A Phase Ib/II Study of MBP-426 in Patients With Second Line Gastric, Gastro Esophageal, or Esophageal Adenocarcinoma
Status: Archived
Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma
Updated: 1/1/1970
A Phase Ib/II Study of MBP-426 in Patients With Second Line Gastric, Gastro Esophageal, or Esophageal Adenocarcinoma
Status: Archived
Updated: 1/1/1970
Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma
A Phase Ib/II Study of MBP-426 in Patients With Second Line Gastric, Gastro Esophageal, or Esophageal Adenocarcinoma
Status: Archived
Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma
Updated: 1/1/1970
A Phase Ib/II Study of MBP-426 in Patients With Second Line Gastric, Gastro Esophageal, or Esophageal Adenocarcinoma
Status: Archived
Updated: 1/1/1970
Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma
A Phase Ib/II Study of MBP-426 in Patients With Second Line Gastric, Gastro Esophageal, or Esophageal Adenocarcinoma
Status: Archived
Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma
Updated: 1/1/1970
A Phase Ib/II Study of MBP-426 in Patients With Second Line Gastric, Gastro Esophageal, or Esophageal Adenocarcinoma
Status: Archived
Updated: 1/1/1970
Effects of Gastric Antral Botulinum Toxin Injections in Obese Subjects
Physiologic Effects of High-Dose Gastric Antral Botulinum Toxin Injections
Status: Archived
Effects of Gastric Antral Botulinum Toxin Injections in Obese Subjects
Updated: 1/1/1970
Physiologic Effects of High-Dose Gastric Antral Botulinum Toxin Injections
Status: Archived
Updated: 1/1/1970
Microparticles in Pediatric Inflammatory Disease
Microparticles in Pediatric Inflammatory Bowel Disease
Status: Archived
Microparticles in Pediatric Inflammatory Disease
Updated: 1/1/1970
Microparticles in Pediatric Inflammatory Bowel Disease
Status: Archived
Updated: 1/1/1970
Single Incision Laparoscopic Surgery (SILS) Versus Laparoscopic Appendectomy
Single Incision Versus Standard Laparoscopic Appendectomy for Non-Perforated Appendicitis
Status: Archived
Single Incision Laparoscopic Surgery (SILS) Versus Laparoscopic Appendectomy
Updated: 1/1/1970
Single Incision Versus Standard Laparoscopic Appendectomy for Non-Perforated Appendicitis
Status: Archived
Updated: 1/1/1970
Single Incision Laparoscopic Surgery (SILS) Versus Laparoscopic Cholecystectomy
Single Incision Versus Laparoscopic Cholecystectomy
Status: Archived
Single Incision Laparoscopic Surgery (SILS) Versus Laparoscopic Cholecystectomy
Updated: 1/1/1970
Single Incision Versus Laparoscopic Cholecystectomy
Status: Archived
Updated: 1/1/1970
Laparoscopic Versus Open Pancreatectomy
Randomized Trial of Laparoscopic Versus Open Distal Pancreatectomy in Patients With Pancreatic Disease
Status: Archived
Laparoscopic Versus Open Pancreatectomy
Updated: 1/1/1970
Randomized Trial of Laparoscopic Versus Open Distal Pancreatectomy in Patients With Pancreatic Disease
Status: Archived
Updated: 1/1/1970
New Neural Drug Targets
New Neural Drug Targets: An Evaluation of the Effects of Aprepitant on the Response to Oxycodone
Status: Archived
New Neural Drug Targets
Updated: 1/1/1970
New Neural Drug Targets: An Evaluation of the Effects of Aprepitant on the Response to Oxycodone
Status: Archived
Updated: 1/1/1970
Anesthetic Effects in Mitochondrial Disease
Anesthetic Effects in Mitochondrial Disease
Status: Archived
Anesthetic Effects in Mitochondrial Disease
Updated: 1/1/1970
Anesthetic Effects in Mitochondrial Disease
Status: Archived
Updated: 1/1/1970
The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease
The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 (FGF23 ) in Chronic Kidney Disease
Status: Archived
The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease
Updated: 1/1/1970
The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 (FGF23 ) in Chronic Kidney Disease
Status: Archived
Updated: 1/1/1970
Effect of Tranexamic Acid in Upper Gastrointestinal Bleeding
Effect of Tranexamic Acid on Blood Transfusion in Upper Gastrointestinal Bleeding
Status: Archived
Effect of Tranexamic Acid in Upper Gastrointestinal Bleeding
Updated: 1/1/1970
Effect of Tranexamic Acid on Blood Transfusion in Upper Gastrointestinal Bleeding
Status: Archived
Updated: 1/1/1970
Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery
Assessment of Insulin Resistance, Non-Alcoholic Fatty Liver Disease, Predictors of Cardiovascular Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass: Development of a New Paradigm in Defining "Morbid Obesity" and in the Application of Bariatric Surgery
Status: Archived
Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery
Updated: 1/1/1970
Assessment of Insulin Resistance, Non-Alcoholic Fatty Liver Disease, Predictors of Cardiovascular Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass: Development of a New Paradigm in Defining "Morbid Obesity" and in the Application of Bariatric Surgery
Status: Archived
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Comparison of Standard of Care or Treatment on Protocol
Randomized Study of Patients (Patient Choice) Who Are Not Eligible for Variations of Standard of Care Protocols When Treated Either on Best Standard of Care Pathways or Per a Protocol Arm That They Failed to Enroll to
Status: Archived
Comparison of Standard of Care or Treatment on Protocol
Updated: 1/1/1970
Randomized Study of Patients (Patient Choice) Who Are Not Eligible for Variations of Standard of Care Protocols When Treated Either on Best Standard of Care Pathways or Per a Protocol Arm That They Failed to Enroll to
Status: Archived
Updated: 1/1/1970
Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease
The Effect of Vitamin D Supplementation on Markers of Inflammation in High-Risk Cardiovascular Patients With Low Levels of Serum 25-Hydroxyvitamin D
Status: Archived
Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease
Updated: 1/1/1970
The Effect of Vitamin D Supplementation on Markers of Inflammation in High-Risk Cardiovascular Patients With Low Levels of Serum 25-Hydroxyvitamin D
Status: Archived
Updated: 1/1/1970
The Effect of Weight on Vitamin D Dose Response
The Effect of Weight on Vitamin D Dose Response
Status: Archived
The Effect of Weight on Vitamin D Dose Response
Updated: 1/1/1970
The Effect of Weight on Vitamin D Dose Response
Status: Archived
Updated: 1/1/1970
Hepatic Impaired Subjects Compared to Healthy Subjects Receiving Multi-dose BMS-650032
Multiple-Dose Pharmacokinetics of BMS-650032 in Subjects With Hepatic Impairment Compared to Healthy Subjects
Status: Archived
Hepatic Impaired Subjects Compared to Healthy Subjects Receiving Multi-dose BMS-650032
Updated: 1/1/1970
Multiple-Dose Pharmacokinetics of BMS-650032 in Subjects With Hepatic Impairment Compared to Healthy Subjects
Status: Archived
Updated: 1/1/1970
Hepatic Impaired Subjects Compared to Healthy Subjects Receiving Multi-dose BMS-650032
Multiple-Dose Pharmacokinetics of BMS-650032 in Subjects With Hepatic Impairment Compared to Healthy Subjects
Status: Archived
Hepatic Impaired Subjects Compared to Healthy Subjects Receiving Multi-dose BMS-650032
Updated: 1/1/1970
Multiple-Dose Pharmacokinetics of BMS-650032 in Subjects With Hepatic Impairment Compared to Healthy Subjects
Status: Archived
Updated: 1/1/1970
Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
A Phase I Double-blind, Randomized, Comparator-controlled Study of the Safety and Tolerability of N-acetylcysteine Plus Mesalamine Enema in Subjects With Left-sided Ulcerative Colitis
Status: Archived
Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Updated: 1/1/1970
A Phase I Double-blind, Randomized, Comparator-controlled Study of the Safety and Tolerability of N-acetylcysteine Plus Mesalamine Enema in Subjects With Left-sided Ulcerative Colitis
Status: Archived
Updated: 1/1/1970
Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers
A Randomized, Controlled Trial of the Procelleraâ„¢ Wound Dressing Used With Negative Pressure Wound Therapy (NPWT) in the Healing of Diabetic and Pressure Ulcers of the Foot
Status: Archived
Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers
Updated: 1/1/1970
A Randomized, Controlled Trial of the Procelleraâ„¢ Wound Dressing Used With Negative Pressure Wound Therapy (NPWT) in the Healing of Diabetic and Pressure Ulcers of the Foot
Status: Archived
Updated: 1/1/1970